chr17-5023910-G-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_006612.6(KIF1C):​c.3071G>C​(p.Arg1024Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,558,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1024Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000039 ( 0 hom. )

Consequence

KIF1C
NM_006612.6 missense

Scores

5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.19

Publications

5 publications found
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C-AS1 (HGNC:40324): (KIF1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23872164).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000391 (55/1406406) while in subpopulation MID AF = 0.000365 (2/5474). AF 95% confidence interval is 0.0000639. There are 0 homozygotes in GnomAdExome4. There are 32 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006612.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1C
NM_006612.6
MANE Select
c.3071G>Cp.Arg1024Pro
missense
Exon 23 of 23NP_006603.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1C
ENST00000320785.10
TSL:1 MANE Select
c.3071G>Cp.Arg1024Pro
missense
Exon 23 of 23ENSP00000320821.5
KIF1C-AS1
ENST00000438266.2
TSL:2
n.172-2955C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152064
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000440
AC:
9
AN:
204758
AF XY:
0.0000636
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000863
Gnomad OTH exome
AF:
0.000207
GnomAD4 exome
AF:
0.0000391
AC:
55
AN:
1406406
Hom.:
0
Cov.:
35
AF XY:
0.0000461
AC XY:
32
AN XY:
694292
show subpopulations
African (AFR)
AF:
0.0000316
AC:
1
AN:
31614
American (AMR)
AF:
0.00
AC:
0
AN:
36482
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22326
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38946
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78338
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51536
Middle Eastern (MID)
AF:
0.000365
AC:
2
AN:
5474
European-Non Finnish (NFE)
AF:
0.0000452
AC:
49
AN:
1083844
Other (OTH)
AF:
0.0000519
AC:
3
AN:
57846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152064
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41396
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000151
Hom.:
0
Bravo
AF:
0.0000264
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000825
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Spastic ataxia 2 Uncertain:1
Dec 18, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 1024 of the KIF1C protein (p.Arg1024Pro). This variant is present in population databases (rs141225452, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with KIF1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 2039348). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.057
T
Eigen
Benign
0.18
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.76
D
LIST_S2
Benign
0.77
T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.24
T
MetaSVM
Uncertain
-0.28
T
MutationAssessor
Benign
0.69
N
PhyloP100
2.2
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.25
N
REVEL
Benign
0.20
Sift
Uncertain
0.020
D
Sift4G
Benign
0.32
T
Polyphen
0.99
D
Vest4
0.27
MutPred
0.22
Gain of glycosylation at R1024 (P = 0.0045)
MVP
0.78
MPC
0.83
ClinPred
0.22
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.33
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141225452; hg19: chr17-4927205; API